ReviewFrontiers in immunology2022
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice.
Mohammad Reza Hatamnejad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it